The effects of neonicotinoid insecticides on female reproductive health
Official title: Neonicotinoid insecticides and female reproduction
Funded at University of Illinois at Urbana-Champaign · NIH-10936899 · Data updated 2026-11-12
This study looks at how a common insecticide called Imidacloprid might affect women's reproductive health by potentially causing problems in the ovaries, and it's designed for anyone interested in understanding the risks of everyday agricultural chemicals.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2026 |
| Funding year | 2024 |
| Award (this year) | $411,847 |
| NIH project number | 1R21ES036520-01 |
| Project ID | NIH-10936899 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adult women who may have been exposed to neonicotinoid insecticides through food, water, or environmental contact.
✕Less likely to help
Patients who are not adult women or those who have not been exposed to neonicotinoids may not benefit from this research.
What this research studies
This research investigates how exposure to neonicotinoid insecticides, particularly Imidacloprid, affects female reproductive health. It focuses on the potential bioactivation of this insecticide in the ovaries, leading to the production of a more toxic compound that may disrupt normal follicle growth and hormone production. The study will involve laboratory experiments to assess the impact of this compound on ovarian function and reproductive outcomes. By understanding these effects, the research aims to highlight the risks associated with common agricultural chemicals.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of reproductive health risks associated with agricultural chemicals in women.
How similar studies have gone: While the specific focus on neonicotinoids and female reproduction is relatively novel, there is growing evidence linking agricultural chemicals to reproductive health issues in other studies.
Where this research is happening
-
University of Illinois at Urbana-Champaign
Champaign, United States Active
Researchers
- Principal investigator: Flaws, Jodi a. — University of Illinois at Urbana-Champaign
- Study coordinator: Flaws, Jodi a.
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
HIV in Women: How the virus hides and the immune system changes across life stages
This project looks at how HIV behaves differently in people from puberty through menopause, focusing on how hormones like estrogen may affect HIV persistence and immune responses.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
Computational modeling of female hormone balance and drug responses
A new computational model uses patient-like data to predict how metabolic drugs will work in women across their hormonal cycles and different reproductive stages.
-
How PrEP Drugs Affect HIV Risk in Women and Reproductive Health
This project looks at how PrEP medicines work for women, and whether they influence pregnancy-related processes in the uterus.
-
How female eggs throw away most chromosomes during meiosis
A scientist at UC Davis is studying why only a quarter of chromosomes go into the egg during female reproductive cell division and how errors in this process can cause miscarriage or birth defects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.